Analyst Ratings for Sunesis Pharmaceuticals Inc. (SNSS)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.8 / 10
Percentile Rank: 36%
Rating Score: 3.8 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/23/2021 | Oppenheimer | Hartaj Singh | Upgrade | Outperform (Perform) |
12.00 (N/A) |
3.66 (5.32) |
45.36% | Details |
| 3/11/2020 | Wells Fargo | Jim Birchenough | Downgrade | Equal Weight (Overweight) |
1.00 (N/A) |
0.97 (5.32) |
448.45% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


